These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23242761)

  • 1. Treatment options for hepatitis delta virus infection.
    Heidrich B; Manns MP; Wedemeyer H
    Curr Infect Dis Rep; 2013 Feb; 15(1):31-8. PubMed ID: 23242761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis delta: immunopathogenesis and clinical challenges.
    Grabowski J; Wedemeyer H
    Dig Dis; 2010; 28(1):133-8. PubMed ID: 20460901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Delta Hepatitis: Today and in the Future - A review.
    Bahcecioglu IH; Sahin A
    Infect Dis (Lond); 2017 Apr; 49(4):241-250. PubMed ID: 28092214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future treatments for hepatitis delta virus infection.
    Asselah T; Loureiro D; Tout I; Castelnau C; Boyer N; Marcellin P; Mansouri A
    Liver Int; 2020 Feb; 40 Suppl 1():54-60. PubMed ID: 32077603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapies for hepatitis delta virus infection.
    Loureiro D; Castelnau C; Tout I; Boyer N; Narguet S; Menasria Benazzouz S; Louis Z; Pons-Kerjean N; Giuly N; Marcellin P; Mansouri A; Asselah T
    Liver Int; 2021 Jun; 41 Suppl 1():30-37. PubMed ID: 34155804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of delta hepatitis.
    Gunsar F
    Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
    Keskin O; Wedemeyer H; Tüzün A; Zachou K; Deda X; Dalekos GN; Heidrich B; Pehlivan S; Zeuzem S; Yalçın K; Gürel S; Tabak F; Idilman R; Bozkaya H; Manns M; Yurdaydin C
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2342-49.e1-2. PubMed ID: 26044319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of Delta Hepatitis.
    Yurdaydin C; Idilman R
    Cold Spring Harb Perspect Med; 2015 Aug; 5(10):. PubMed ID: 26253093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.
    Khabir M; Aliche AZ; Sureau C; Blanchet M; Labonté P
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.
    Giersch K; Perez-Gonzalez P; Hendricks L; Goldmann N; Kolbe J; Hermanussen L; Bockmann JH; Volz T; Volmari A; Allweiss L; Petersen J; Glebe D; Lütgehetmann M; Dandri M
    JHEP Rep; 2023 Apr; 5(4):100673. PubMed ID: 36908749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
    Lempp FA; Volz T; Cameroni E; Benigni F; Zhou J; Rosen LE; Noack J; Zatta F; Kaiser H; Bianchi S; Lombardo G; Jaconi S; Vincenzetti L; Imam H; Soriaga LB; Passini N; Belnap DM; Schulze A; Lütgehetmann M; Telenti A; Cathcart AL; Snell G; Purcell LA; Hebner CM; Urban S; Dandri M; Corti D; Schmid MA
    J Hepatol; 2023 Nov; 79(5):1129-1138. PubMed ID: 37459920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aiming for cure in HBV and HDV infection.
    Petersen J; Thompson AJ; Levrero M
    J Hepatol; 2016 Oct; 65(4):835-848. PubMed ID: 27270043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on hepatitis D: From virology to new therapies.
    Mentha N; Clément S; Negro F; Alfaiate D
    J Adv Res; 2019 May; 17():3-15. PubMed ID: 31193285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
    J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.
    Heidrich B; Yurdaydın C; Kabaçam G; Ratsch BA; Zachou K; Bremer B; Dalekos GN; Erhardt A; Tabak F; Yalcin K; Gürel S; Zeuzem S; Cornberg M; Bock CT; Manns MP; Wedemeyer H;
    Hepatology; 2014 Jul; 60(1):87-97. PubMed ID: 24585488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis D virus: Improving virological knowledge to develop new treatments.
    Khalfi P; Kennedy PT; Majzoub K; Asselah T
    Antiviral Res; 2023 Jan; 209():105461. PubMed ID: 36396025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.